https://www.apeiron-biologics.com/manfred-reichl-awarded-business-angel-of-the-year/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/exclusive-licence-agreement-with-gsk/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/biotech-pharma-partnerships/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/european-biotechnica-award-2010/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/pain-alliance-with-evotec/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-acquires-rights-to-new-clinical-stage-project/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/experienced-venture-capitalist-pharma-manager-joins-apeirons-business-development-team/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-acquires-rights-for-a-phase-ii-biologic-against-neuroblastoma-and-other-cancers-from-merck-kgaa-germany/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-acquires-option-to-license-rights-to-novel-oncology-compounds-from-cleveland-clinic/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-acquires-rights-for-phase-iii-immunotherapy-against-high-risk-neuroblastoma-from-ccri-and-siopen/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/childrens-oncology-group-and-apeiron-to-jointly-conduct-phase-ii-study-in-neuroblastoma-with-hu14-18-il2-apn301/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/evotec-and-apeiron-biologics-start-next-project-on-the-cbl-b-target/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-initiates-clinical-study-to-investigate-prevention-of-radiation-induced-skin-damage-in-breast-cancer-patients/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-was-officially-informed-today-by-viennas-zentrum-fur-innovation-und-technologie-zit-that-a-grant-application-submitted-in-april-2012-for-the-program-fempower-2012-rec/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-establishes-biotech-spinoff-attoquant-diagnostics/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-ag-closes-regional-license-agreement-for-antibody-based-immunotherapy/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/austrian-research-promotion-agency-ffg-provides-funds-of-up-to-eur-745000-for-apeirons-project-apn411/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/positive-outcome-in-clinical-study-to-prevent-radiation-induced-dermatitis-in-breast-cancer-patients/ 2020-07-10T13:04:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-ag-collaborates-with-idis-ltd-to-initiate-managed-access-program/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-signs-regional-license-agreements-with-medison-pharma-israel-and-gen-ilac-ve-saglik-urunleri-turkey-for-the-commercialization-of-its-neuroblastoma-therapy/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-scientists-were-authors-co-authors-on-three-presentations-at-asco-2014-may-30-june-3-2014-chicago/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-to-start-first-clinical-trial-in-japan-with-its-neuroblastoma-therapy-apn311/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-announces-start-of-a-phase-i-trial-with-a-unique-cellular-anti-cancer-therapy-triggering-immunological-checkpoint-blockade/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/evotec-apeiron-biologics-and-sanofi-form-strategic-collaboration/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-and-columbia-university-have-entered-into-an-exclusive-license-agreement-that-expands-apeirons-immune-checkpoint-blockade-ip-portfolio/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-grants-eusa-pharma-global-rights-to-immunotherapy/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-receives-green-light-for-marketing-approval-of-apn311-in-the-european-union/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/marketing-approval-for-childrens-cancer-immunotherapy-in-the-eu-outstanding-success-for-privately-financed-austrian-biotech-company-apeiron/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/nvestment-plan-for-europe-eib-grants-financing-to-apeiron/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-strengthens-management-board-with-industry-expert-peter-llewellyn-davies-as-new-chief-financial-officer/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-announces-publication-of-clinical-data-with-anti-gd2-antibody-demonstrating-efficacy-in-relapsed-refractory-high-risk-neuroblastoma/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-to-present-at-the-biotech-showcase-annual-conference-2018/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-and-evotec-achieve-first-milestone-in-immuno-oncology-alliance-with-sanofi/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-ag-to-present-clinical-data-at-the-forthcoming-annual-meeting-of-the-american-society-of-clinical-oncology-asco/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/eib-blog-featuring-apeiron-three-ways-to-treat-cancer/ 2020-07-10T13:03:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-the-medical-university-of-vienna-and-the-institute-of-molecular-biotechnology-sign-licensing-agreement-for-a-new-checkpoint-inhibitor/ 2020-12-04T15:19:14+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-appoints-peter-llewellyn-davies-as-chief-executive-officer/ 2020-12-04T15:18:54+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron_announces_collaboration_with_lead_discovery_center/ 2020-12-04T15:18:29+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeirons-respiratory-drug-product-to-start-pilot-clinical-trial-to-treat-coronavirus-disease-covid-19-in-china/ 2020-12-04T15:18:09+00:00 monthly 0.2 https://www.apeiron-biologics.com/our-work-on-a-potential-drug-candidate-for-covid-19/ 2021-05-19T11:22:48+00:00 monthly 1.0 https://www.apeiron-biologics.com/apeiron-biologics-announces-financing-round-for-further-development-of-the-covid-19-drug-apn01/ 2020-12-04T15:09:25+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-closes-oversubscribed-financing-round-of-eur-17-5-million-for-the-development-of-apn01-against-covid-19-expansion-of-the-ongoing-phase-ii-clinical-trial-to-usa-and-russia-planned/ 2020-12-04T14:11:00+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-and-maxcyte-enter-into-clinical-and-commercial-licensing-agreement-for-apn401/ 2020-12-04T15:02:41+00:00 monthly 0.2 https://www.apeiron-biologics.com/the-lancet-publishes-promising-data-of-apeirons-apn01-rhsace2-to-treat-covid-19-in-named-patient-use/ 2020-12-04T14:42:09+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-ag-strengthens-shareholder-structure-and-supervisory-board-with-international-anchor-investor/ 2021-04-16T09:30:57+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-ag-and-domainex-ltd-announce-the-expansion-of-their-partnership-to-progress-targeted-cancer-immune-therapy-drug-discovery/ 2020-12-04T14:55:22+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-patient-recruitment-completed-in-phase-ii-covid-19-clinical-trial-of-apn01/ 2020-12-04T14:26:10+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeirons-apn01-shows-clinical-benefits-for-severely-ill-covid-19-patients-in-phase-2-trial/ 2021-03-12T07:23:36+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-apn01-selected-for-large-scale-us-trial-in-covid-19/ 2021-05-19T13:38:39+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-announces-changes-to-management-and-supervisory-boards/ 2021-06-01T09:53:30+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-launches-next-clinical-trial-with-innovative-cancer-therapy-apn401/ 2021-07-05T20:09:02+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-commences-clinical-covid-19-trial-with-inhaled-apn01/ 2021-10-11T13:23:47+00:00 monthly 0.2 https://www.apeiron-biologics.com/invios-goes-live-with-unique-cell-therapy-platform-and-clinical-stage-immuno-oncology-pipeline/ 2021-12-16T09:10:02+00:00 monthly 0.2 https://www.apeiron-biologics.com/apeiron-biologics-to-be-acquired-by-ligand-pharmaceuticals-for-usd-100-million/ 2024-07-08T14:38:10+00:00 monthly 0.2